FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “NanoVibronix Independent Study Reveals Positive Results for its UroShield Device”
NanoVibronix (NASDAQ: NAOV) surged 151% in premarket trading after the company announced positive findings from an independent evaluation of its UroShield® device.
An independent study reported statistically significant outcomes for the UroShield, demonstrating a reduction in the number of UTIs, catheter blockages, unplanned catheter changes and pain reported as a result of catheter associated complications in patients who have used the device for up to two years.
NanoVibronix, Inc. is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The Company’s primary products include PainShield®, UroShield® and WoundShield®, all of which are portable devices suitable for administration at home without assistance of medical professionals.
For more information, please visit: NanoVibronix, Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.